NYSE •
Real Estate •
REIT - Office •
Quote as of 09/17/2026 16:00
Company Profile
IndustryREIT - Office
SectorReal Estate
ExchangeNYSE
Market Capitalization9,109 mln
Float124 mln
Earnings Date10/26/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-2.46
Borderline
1-Year Forecast
53.00
Limited downside
Relative Strength
96
/ 100
Top performer
Debt / Equity
0.85
Moderate leverage
Pre-Tax Margin
-30%
Deeply loss-making
Business Description
Alexandria Real Estate Equities is a publicly traded company that owns, operates, and develops properties specifically designed for life science organizations such as biotech and pharmaceutical firms. Founded in 1994, the company focuses on building large, interconnected campuses in key research hubs across the United States, including Boston, San Diego, Seattle, and New York City. With a total market capitalization of approximately $20.75 billion and nearly 40 million square feet of property in operation or under construction, Alexandria serves a broad range of tenants in the life sciences sector. The company also invests directly in life science businesses through its venture capital arm, adding another dimension to its role in supporting scientific and medical innovation.
